Today, Robinhood Ventures Fund I (RVI) announced the pricing of its initial public offering of 12,615,608 common shares of ...

Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...

Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...

At the center of those concerns is the Strait of Hormuz, the narrow waterway through which roughly one-fifth of the world’s oil supply passes. While Iranian officials have denied initiating a blockade ...

IMPERIAL PETROLEUM INC. (NASDAQ: IMPP; the “Company”), a ship-owning company providing petroleum products, crude oil and dry bulk seaborne transportation services, announced today its unaudited ...

All Four Post-Quantum Security Products on Track for Common Criteria, FIPS 140-3, and TCG Certifications Through Q4 2026 SEALSQ Corp (Nasdaq: LAES), ("SEALSQ" or "Company"), a leading provider of post ...

Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric ...

The Special Meeting is scheduled to be held at 10:00 a.m., Pacific Time, on March 13, 2026, at the Company’s principal executive offices. Subject to stockholder approval of the Business Combination ...

Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the fourth quarter and year ended ...

Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the second quarter (twelve weeks) and the first 24 weeks of fiscal 2026, ended ...

Q4 total sales grew 11%, and comparable store sales increased 4% Q4 net income was $310 million, and diluted EPS was $4.84 FY25 total sales grew ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics ...